Peptide Association
Start Your Consultation
All peptides
RecoveryResearch Phase

Pentadeca Arginate (PDA)

Subcutaneous injection, Topical
Written by Peptide Association Editorial TeamMedically reviewed by Ian Justl Ellis, MD, CPTLast reviewed Editorial policy

Overview

Pentadeca Arginate is a synthetic 15-arginine polypeptide designed to enhance cellular uptake and delivery of therapeutic molecules. The polyarginine structure confers cell-penetrating properties by interacting with negatively charged cell membrane components.

Mechanism of Action

It has been explored as a carrier for facilitating intracellular delivery of bioactive compounds and as a potential modulator of tissue repair processes.

Research Summary & Key Findings

Preclinical in vitro studies have demonstrated efficient cellular internalization and low cytotoxicity in various cell lines. Animal studies investigating wound healing and tissue repair applications have shown preliminary evidence of enhanced regeneration, though mechanisms remain incompletely characterized. No clinical trial data in humans are currently available.

Clinical Status

Research Phase

Pentadeca Arginate (PDA) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Subcutaneous injectionTopical

References

Primary literature

Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.

Related Peptides in Recovery

BPC-157

Research Phase

A synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis ...

View details

TB-500 (Thymosin Beta-4)

In Clinical Trials

Thymosin Beta-4 is a 43-amino acid actin-sequestering protein involved in cell migration, differentiation, and tissue re...

View details

GHK-Cu

Research Phase

A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. G...

View details

DSIP (Delta Sleep-Inducing Peptide)

Research Phase

A naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood o...

View details

Start Your Consultation

Get an AI-proposed Pentadeca Arginate (PDA) protocol reviewed by a physician in our network.

Start Your Consultation

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Pentadeca Arginate (PDA).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.